LAVA Therapeutics (LVTX) Names Peter A Kiener, Mary Wadlinger to board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Nouscom appoints Göran Ando MD as Chairman and Richard Davis PhD as Chief Business Officer
News provided by
Share this article
Share this article
BASEL, Switzerland, Dec. 11, 2020 /PRNewswire/ Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized genetic cancer vaccines, today announces that it has appointed Göran Ando, MD as the new Chairman of its Board of Directors. Nouscom also appointed Richard Davis, PhD as Chief Business Officer (CBO).
Dr. Guido Magni, former Chairman and Director of the Board, said:
I am delighted to welcome Dr. Ando, an experienced biopharmaceutical executive, to the company. It has been a pleasure to chair Nouscom s Board over the past years and I look forward to continuing working with the company as a Director going forward.